High‐dose‐rate versus low‐dose‐rate intracavitary therapy for carcinoma of the uterine cervix
Open Access
- 28 December 2001
- Vol. 94 (1) , 117-124
- https://doi.org/10.1002/cncr.10207
Abstract
BACKGROUND This was a prospective randomized clinical trial undertaken at our institution to compare low-dose-rate (LDR) intracavitary radiation therapy versus high-dose-rate (HDR) intracavitary radiation therapy for the treatment of cervical carcinoma. METHODS From January 1984 to December 1997, a total of 132 patients with Stage II or IIIB of invasive carcinoma of the uterine cervix were entered into this randomized study. Treatment arm by HDR or LDR was allocated according to the month of each patient's birth. External irradiation consisted of whole pelvis irradiation and pelvic irradiation. Doses of external irradiation for both groups were identical. The authors used 0.588 as the conversion factor of total intracavitary dose from LDR to HDR. RESULTS The 5-year disease specific survival rates of Stage II and III patients treated with HDR were 69% and 51% whereas those with LDR were 87% and 60%, respectively. The 5-year pelvic recurrence free survival rates of Stage II and III patients treated with HDR were 89% and 73% whereas those with LDR were 100% and 70%, respectively. There was no significant difference in disease specific survival or pelvic recurrence free survival rates between HDR and LDR. The actuarial complication rate (Radiation Therapy Oncology Group Grade 3, 4, or 5) at 5 years was 10% in the HDR group and 13% in the LDR group, and the difference between the HDR and LDR groups was not statistically significant. CONCLUSIONS The pelvic control or actuarial complication rates were comparable between HDR and LDR treatment. The difference between the disease specific survival rates for HDR and LDR was not statistically significant for Stage II or III, although in Stage II, patients treated with LDR appeared to have a better survival rate than those treated with HDR. Cancer 2002;94:117–24. © 2002 American Cancer Society.Keywords
This publication has 25 references indexed in Scilit:
- National Institutes of Health Consensus Development Conference Statement on Cervical CancerGynecologic Oncology, 1997
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology*Biology*Physics, 1995
- Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: A clinical trialInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionationInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: A final report of the 1973 and 1978 patterns of care studiesInternational Journal of Radiation Oncology*Biology*Physics, 1991
- High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervixInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Intracavitary Irradiation of Carcinoma of the Cervix Stage Ib and IIA: A clinical comparison between a remote high dose-rate afterloading system and a low dose-rate manual systemActa Radiologica: Oncology, 1985
- Therapeutic results using high-dose-rate intracavitary irradiation in cases of cervical cancerGynecologic Oncology, 1984
- Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with high-dose rate: A comparative study with a low-dose rate systemInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958